The Impact of Obesity on Outcomes Following Resection for Gastric Cancer

Digestive Surgery

Volumn 34, Issue 2, 2017, Pages 133-141

  Struecker, Benjamin ^a,b   Biebl, Matthias ^a   Dadras, Mehran ^a   Chopra, Sascha ^a   Denecke, Christian ^a   Spenke, Johanna ^a   Heilmann, Ann Christin ^a   Bahra, Marcus ^a   Sauer, Igor Maximilian ^a   Pratschke, Johann ^a   Andreou, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BERLIN INSTITUTE OF HEALTH   (Germany)

Author keywords

Gastrectomy; Gastric cancer; Obesity; Postoperative complications; Preoperative risk factors

Indexed keywords

ADULT; ADVERSE EFFECTS; AGED; BODY MASS; CANCER GRADING; CANCER STAGING; COMPLICATION; FEMALE; GASTRECTOMY; HUMAN; LENGTH OF STAY; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; OBESITY; OPERATION DURATION; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDY; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; FEMALE; GASTRECTOMY; HUMANS; LENGTH OF STAY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; OBESITY; OPERATIVE TIME; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84990206417     PISSN: 02534886     EISSN: 14219883     Source Type: Journal    
DOI: 10.1159/000449043     Document Type: Article

References (27)

1. WHO Media Centre. Obesity and Overweight.
2. Haslam DW, James WP: Obesity. Lancet 2005;366:1197-1209.
3. Lee CT, et al. Impact of body mass index on radical cystectomy. J Urol 2004;172(4 pt 1):1281-1285.
4. Fasol R, et al. The influence of obesity on perioperative morbidity: retrospective study of 502 aortocoronary bypass operations. Thorac Cardiovasc Surg 1992;40:126-129.
5. Holley JL, et al. Obesity as a risk factor following cadaveric renal transplantation. Transplantation 1990;49:387-389.
6. Hutagalung R, et al. The obesity paradox in surgical intensive care unit patients. Intensive Care Med 2011;37:1793-1799.
7. Hogue CW, et al. The impact of obesity on outcomes after critical illness: a meta-analysis. Intensive Care Med 2009;35:1152-1170.
8. Mullen JT, Moorman DW, Davenport DL: The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 2009;250:166-172.
9. Rao S, et al. Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer. Br J Cancer 2008;99:868-874.
10. Ychou M, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 2011;29:1715-1721.
11. Thuss-Patience PC, et al. Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO){dagger}. Ann Oncol 2012;23:2827-2834.
12. Marano L, et al. Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the 'N' parameter-related survival: the monoinstitutional NodUs Italian study. World J Surg Oncol 2015;13:215.
13. Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
14. Flegal KM, Kit BK, Orpana H, Graubard BI: Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013;309:71-82.
15. Klasen J, et al. Increased body mass index and peri-operative risk in patients undergoing non-cardiac surgery. Obes Surg 2004;14:275-281.
16. Giles KA, et al. The impact of body mass index on perioperative outcomes of open and endovascular abdominal aortic aneurysm repair from the National Surgical Quality Improvement Program, 2005-2007. J Vasc Surg 2010;52:1471-1477.
17. Gruberg L, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002;39:578-584.
18. Gurm HS, et al. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol 2002;90:42-45.
19. Lavie CJ, Osman AF, Milani RV, Mehra MR: Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 2003;91:891-894.
20. Aldawood A, Arabi Y, Dabbagh O: Association of obesity with increased mortality in the critically ill patient. Anaesth Intensive Care 2006;34:629-633.
21. Oliveros H, Villamor E: Obesity and mortality in critically ill adults: a systematic review and meta-analysis. Obesity (Silver Spring) 2008;16:515-521.
22. Tokunaga M, et al. Better 5-year survival rate following curative gastrectomy in overweight patients. Ann Surg Oncol 2009;16:3245-3251.
23. Valentijn TM, et al. The obesity paradox in the surgical population. Surgeon 2013;11:169-176.
24. Kulig J, et al. Implications of overweight in gastric cancer: a multicenter study in a Western patient population. Eur J Surg Oncol 2010;36:969-976.
25. Bickenbach KA, et al. Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Ann Surg Oncol 2013;20:780-787.
26. Yasunaga H, et al. Body mass index and outcomes following gastrointestinal cancer surgery in Japan. Br J Surg 2013;100:1335-1343.
27. Pata G, Solaini L, Roncali S, Pasini M, Ragni F: Impact of obesity on early surgical and oncologic outcomes after total gastrectomy with 'over-D1' lymphadenectomy for gastric cancer. World J Surg 2013;37:1072-1081.